Nektar Therapeutics short interest in 2022
In 2022, Nektar Therapeutics's disclosed short interest ran from 10.03% of shares outstanding on 14 Jan 2022 to 4.79% on 30 Dec 2022, a change of -5.24 percentage points. The year's high was 12.89% on 15 Mar 2022 and its low 4.79% on 30 Dec 2022, averaging 9.79% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.07 days on 15 Nov 2022. Full history: Nektar Therapeutics.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 10.03% (14 Jan 2022)
- End of year
- 4.79% (30 Dec 2022)
- Change
- -5.24 pp
- High
- 12.89% (15 Mar 2022)
- Low
- 4.79% (30 Dec 2022)
- Average
- 9.79%
- Highest days to cover
- 14.07 (15 Nov 2022)
- SEC filings marked
- 10
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 10.03% | 8.49 | results (8-K) |
| 31 Jan 2022 | 10.66% | 8.62 | |
| 15 Feb 2022 | 11.15% | 11.47 | |
| 28 Feb 2022 | 11.56% | 12.43 | results (8-K) |
| 15 Mar 2022 | 12.89% | 5.12 | 10-K filed |
| 31 Mar 2022 | 11.33% | 4.80 | |
| 14 Apr 2022 | 11.07% | 4.94 | |
| 29 Apr 2022 | 9.84% | 3.06 | results (8-K) |
| 13 May 2022 | 9.72% | 5.42 | results (8-K), 10-Q filed |
| 31 May 2022 | 9.59% | 6.16 | |
| 15 Jun 2022 | 9.47% | 7.21 | |
| 30 Jun 2022 | 10.80% | 3.66 | |
| 15 Jul 2022 | 12.65% | 5.47 | |
| 29 Jul 2022 | 10.14% | 8.76 | |
| 15 Aug 2022 | 10.07% | 8.77 | results (8-K), 10-Q filed |
| 31 Aug 2022 | 9.41% | 12.07 | |
| 15 Sep 2022 | 9.39% | 9.62 | |
| 30 Sep 2022 | 9.34% | 8.56 | |
| 14 Oct 2022 | 9.28% | 9.29 | |
| 31 Oct 2022 | 9.23% | 13.36 | |
| 15 Nov 2022 | 8.93% | 14.07 | results (8-K), 10-Q filed |
| 30 Nov 2022 | 8.76% | 10.92 | |
| 15 Dec 2022 | 4.87% | 3.40 | |
| 30 Dec 2022 | 4.79% | 5.87 |
See also: Nektar Therapeutics's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.